I think this is the logical thing to do, but now there are two new roadblocks clinical trials have to face: * It's hard to recruit non-vaccinated participants

I think this is the logical thing to do, but now there are two new roadblocks clinical trials have to face: * It's hard to recruit non-vaccinated participants * There will be safety issues to address on people that have received multiple shots and / or designed against different strains